Literature DB >> 7896752

cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

Y Miyagi1, N Koshikawa, H Yasumitsu, E Miyagi, F Hirahara, I Aoki, K Misugi, M Umeda, K Miyazaki.   

Abstract

A serine proteinase inhibitor was purified from conditioned medium of the human glioblastoma cell line T98G. Analysis of its partial amino acid sequences indicated that this protein was identical to placental protein 5 (PP5), a placenta-derived glycoprotein with serine proteinase inhibitor activity, the amino acid sequence of which had been partially determined. cDNA cloning of PP5 demonstrated that it belonged to the Kunitz-type serine proteinase inhibitor family, having three putative Kunitz-type inhibitor domains, and that it was identical to a recently reported inhibitor, tissue factor pathway inhibitor-2 (TFPI-2) [Sprecher et al. (1994) Proc. Natl. Acad. Sci. USA 91, 3353-3357]. PP5/TFPI-2 transcripts were highly abundant in the full-term placenta and widely expressed in various adult human tissues, such as the liver, skeletal muscle, heart, kidney, and pancreas. Several ovarian carcinoma cells as well as T98G also contained significant amounts of the transcripts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7896752     DOI: 10.1093/oxfordjournals.jbchem.a124648

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  18 in total

1.  Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.

Authors:  S D Konduri; A Tasiou; N Chandrasekar; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

3.  In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2.

Authors:  S S Lakka; S D Konduri; S Mohanam; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.

Authors:  E G Fischer; M Riewald; H Y Huang; Y Miyagi; Y Kubota; B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.

Authors:  Shakuntala Kondraganti; Christopher S Gondi; Meena Gujrati; Ian McCutcheon; Dzung H Dinh; Jasti S Rao; William C Olivero
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

Review 6.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

7.  Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma.

Authors:  Yong Xu; Xiaolin Qin; Jinjing Zhou; Zhiguang Tu; Xiao Bi; Wuxian Li; Xiaoqing Fan; Yi Zhang
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

8.  Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.

Authors:  Etsuko Miyagi; Noriaki Arakawa; Kentaro Sakamaki; Naho Ruiz Yokota; Takeharu Yamanaka; Yuki Yamada; Satoshi Yamaguchi; Shoji Nagao; Yasuyuki Hirashima; Yuka Kasamatsu; Hisamori Kato; Tae Mogami; Yohei Miyagi; Hiroshi Kobayashi
Journal:  Int J Clin Oncol       Date:  2021-05-19       Impact factor: 3.850

9.  TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.

Authors:  Shumin Wang; Xue Xiao; Xiaoying Zhou; Tingting Huang; Chunping Du; Nana Yu; Yingxi Mo; Longde Lin; Jinyan Zhang; Ning Ma; Mariko Murata; Guangwu Huang; Zhe Zhang
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

10.  Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.

Authors:  Prakasha Kempaiah; Hitendra S Chand; Walter Kisiel
Journal:  Mol Cancer       Date:  2007-03-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.